A Possible Causal Involvement of Neuroinflammatory, Purinergic P2X7 Receptors in Psychiatric Disorders
Open Access
- 1 November 2022
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Neuropharmacology
- Vol. 20 (11) , 2142-2155
Abstract
P2X7 receptors (Rs) are prominent members of the P2XR family, which after binding ATP, open non-selective cationic channels, thereby allowing the transmembrane passage of Na+, Ca2+, and K+. Long-lasting and repetitive stimulation of the receptor by its agonist leads to the formation of large membrane pores permeable for organic cations of up to 900 Da molecular size. These pores are believed to play a role in apoptosis and inflammation. P2X7Rs are located primarily at peripheral macrophages and microglial cells, the resident macrophages of the CNS. The coactivation of toll-like receptors 4 (TLR4) by lipopolysaccharide, a constituent of the cell membrane of gram-negative bacteria, and the P2X7R by ATP leads to the generation and release of the proinflammatory cytokines interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α. Together with the microglial release of chemokines, reactive oxygen and nitrogen species, proteases, and excitotoxic glutamate, these cytokines result in neurodegeneration. P2X7Rs were found not only to amplify various neurodegenerative illnesses, such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and multiple sclerosis, but also to participate in a range of psychiatric diseases, such as major depression, bipolar disorder, schizophrenia, and an autism spectrum disorder. Based on the prevention/reversal of neuroinflammation, pharmacological antagonists of P2X7Rs and their genetic deletion in animal experiments counteract these deleterious psychiatric conditions. Hence, brain penetrant P2X7R antagonists are potential therapeutics for psychiatric diseases, although the available evidence still needs to be extended and validated by further clinical data.Keywords
Funding Information
- Chengdu University of Traditional Chinese Medicine (CZYHW1901)
- State Administration of Foreign Affairs (G20190236012)
- Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine (ZYYCXTD-D-202003)
- Sichuan Science and Technology Program (2019YFH0108, 2022YFH0006)
This publication has 153 references indexed in Scilit:
- The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in miceInternational Journal of Neuropsychopharmacology, 2013
- Insights into the Molecular Mechanisms Underlying Mammalian P2X7 Receptor Functions and Contributions in Diseases, Revealed by Structural Modeling and Single Nucleotide PolymorphismsFrontiers in Pharmacology, 2013
- Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptorsNature Communications, 2012
- C terminus of the P2X7 receptor: treasure huntingPurinergic Signalling, 2011
- Increased uric acid levels in drug-naïve subjects with bipolar disorder during a first manic episodeProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2010
- Identification and characterization of a novel variant of the human P2X7 receptor resulting in gain of functionPurinergic Signalling, 2009
- Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memoryNeuroscience Letters, 2009
- The P2X7 receptor–pannexin connection to dye uptake and IL-1β releasePurinergic Signalling, 2009
- From inflammation to sickness and depression: when the immune system subjugates the brainNature Reviews Neuroscience, 2008
- A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytesNature, 1992